• Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza | Morningstar

    المصدر: Buzz FX / 23 سبتمبر 2024 09:11:21   America/New_York


    [GlobeNewswire](/news/globe-newswire) Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics,
    Read more...
شارك على،